Candel Therapeutics (CADL) Shares Issued (2020 - 2025)

Candel Therapeutics has disclosed Shares Issued across 5 years of filings, most recently posting -$4.5 million for Q4 2025.

• Shares Issued for Q4 2025 came in at -$4.5 million, down 1322.16% year-over-year; the trailing twelve-month figure through Dec 2025 was $516000.0 (down 69.45% YoY), and the FY2025 annual result was $516000.0, down 69.45% from the prior year.
• Shares Issued came in at -$4.5 million for Q4 2025 at Candel Therapeutics, down from $4.5 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $71.3 million in Q3 2021 to a low of -$70.9 million in Q4 2021.
• The 4-year median for Shares Issued is $72000.0 (2022), against an average of $192785.7.
• Across the five-year window, Shares Issued tumbled 244600.0% in 2021 and soared 295.78% in 2025, its largest moves.
• Candel Therapeutics' Shares Issued stood at -$70.9 million in 2021, then soared by 100.05% to $36000.0 in 2022, then soared by 927.78% to $370000.0 in 2024, then tumbled by 1322.16% to -$4.5 million in 2025.
• The last three Shares Issued figures came in at -$4.5 million (Q4 2025), $4.5 million (Q3 2025), and $108000.0 (Q2 2025), per Business Quant data.